Q4 2024 Earnings Call Transcript March 13, 2025 Akebia Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

The FDA has agreed to review an application from Roche that seeks approval in the U.S. of obinutuzumab as a treatment for ...

Oncorena, a Swedish pharma company, announced that the US FDA has approved the company’s IND application to initiate the phase I/II study Oncorella-1: A phase 1/2, open label, single arm study on ...

Today, having term insurance is no longer considered optional but a necessity. We understand the importance of term insurance ...

Laredo remembers its COVID-19 journey, honoring frontline workers, community efforts and key lessons for future health crises ...

David Hasan, MD, MSc, a practicing neurosurgeon in the US, discusses how he provided health care in a conflict zone on 2 ...

Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and full year 2024 earnings call. At this time, all lines are in a listen only mode. Following the presentation, we will ...

The company has had a productive 2024 with the launch of DefenCath ongoing, and the management has remained in execution mode, establishing commercial agreements with dialysis providers and ...

The UK’s United Utilities has trialled and purchased a water efficient, low energy, phosphorus reduction technology from ...

The economic and operational climate continues to favor big players and industry consolidation this year. As a result, top ...

WEST PALM BEACH, Fla. (CBS12) — A local young man is sharing his story in hopes of raising awareness about kidney failure at any age. Ben Diaz says there weren’t any signs until one day ...